| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2008 | US20080076810 Benzoureas Having Anti-Diabetic Activity |
| 03/27/2008 | US20080076809 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses |
| 03/27/2008 | US20080076808 Pet food of specific dosage of pantothenic acid, nicotinamide, histidine, inositol and choline; treating and preventing skin disorders |
| 03/27/2008 | US20080076807 Treating diseases related to TNF or cytokine overproduction; antitumor agents; autoimmune diseases, neurodegenerative diseases; hydroxamic acid derivatives containing an alpha-aminoacyl moiety such as 4-(2(R)-Benzoylamino-3-naphthalen-2-yl-propionylamino)-N-hydroxy-benzamide |
| 03/27/2008 | US20080076806 Glycine transporter gene 1 (GlyT-1); psychosis, schizophrenia, dementia; activation of NMDA receptors via GlyT-1 inhibition; N-(([(4-chloro-phenyl)-phenyl-methyl]-carbamoyl)-methyl)-4-fluorobenzamide for example |
| 03/27/2008 | US20080076805 Antagonists and/or inverse agonists of CB1; N'-[1-(3-chlorophenyl)-2-(4-chlorophenyl)ethyl]-N'-methyl-N-(2-methyl-2-[5-(trifluoromethylpyridin-2-yl)oxy]propanoyl)hydrazide for example; obesity, psychological disorders, analgesics, drug abuse, constipation, asthma, cirrhosis |
| 03/27/2008 | US20080076804 Methods for inhibiting and breaking age complex formation |
| 03/27/2008 | US20080076803 Antimicrobial preservative comprising a mixture of 1,2-benzisothiazolin-3-one, pyrithione or salts thereof, and an alkalinizing agent to bring the pH to 11 or higher; free of ethylenediamine and N-alkylisothiazolin-3-one; water solubility; high stability at various temperatures, clear concentrates |
| 03/27/2008 | US20080076801 Indolylalkylpyridin-2-amines for the inhibition of beta-secretase |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076799 Piperidinic Derivatives, Pharmaceutic Compositions Containing the Same and Preparation Processes |
| 03/27/2008 | US20080076798 Injectable dosage form of aqueous solution including a buffer and optional amino acid at alkaline pH; e.g. argatroban, lactobionic acid, and methionine; free of ethanol, saccharides and sugar alcohols; reducing dosage errors, storage stability |
| 03/27/2008 | US20080076797 Method of Treating Latent Tuberculosis |
| 03/27/2008 | US20080076796 Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076794 Hyperaldosteronism |
| 03/27/2008 | US20080076793 Use of an ascomycin for the treatment of blepharitis |
| 03/27/2008 | US20080076792 Heterobifunctional Polymeric Bioconjugates |
| 03/27/2008 | US20080076791 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 03/27/2008 | US20080076790 Anticancer agents; 5(R)-(2''-hydroxyethoxy)-20(S)-camptothecin; X-ray powder diffraction |
| 03/27/2008 | US20080076789 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs |
| 03/27/2008 | US20080076788 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use |
| 03/27/2008 | US20080076787 Crystalline antifungal compounds |
| 03/27/2008 | US20080076786 Use of radical-scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 03/27/2008 | US20080076784 Bicyclic, Nitrogen-Containing Heterocycles and Aromatase Inhibitors |
| 03/27/2008 | US20080076783 Cycloalkyl Keto Piperidine Tachykinin Receptor Antagonists |
| 03/27/2008 | US20080076782 Sodium channel blockers |
| 03/27/2008 | US20080076781 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 03/27/2008 | US20080076780 For treatment of cancer; kits |
| 03/27/2008 | US20080076779 Reducing platelets in mammals blood and preventing/treating pro-thrombotic conditions and diseases via inhibitors of anti-apoptotic Bcl-2 family protein members |
| 03/27/2008 | US20080076778 PARP (poly-ADP ribose polymerase); drug screening; computer networks |
| 03/27/2008 | US20080076776 Therapeutic compounds |
| 03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 03/27/2008 | US20080076774 Kinase Modulators and Methods of Use |
| 03/27/2008 | US20080076773 Such as (3R,4R)-1-Pyrimidin-4-yl-4-(2,4,5-trifluorophenyl)piperidin-3-amine bis-trifluoroacetic acid salt |
| 03/27/2008 | US20080076772 Anti-Inflammatory Agents |
| 03/27/2008 | US20080076771 Thrombopoietin Receptor Agonists |
| 03/27/2008 | US20080076770 -[4-(4,5-dichloro-1H-imidazol-1-yl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; useful for treating hypertensive, cardiovascular, inflammatory, and diabetes related diseases |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
| 03/27/2008 | US20080076766 Piperidine Derivatives As Renin Inhibitor |
| 03/27/2008 | US20080076765 4aRS,11bRS)-4-propyl-3,4,4a,5,6,8,9,11b-octahydroisoindolo[5,6-h][1,4]benzoxazin-10(2H)-one or salts useful in the treatment of disorders of CNS that involve the dopaminergic system: Parkinson's disease, hyperprolactinaemia, sexual dysfunction, depression, anxiety, Alzheimer's/neurodegenerative disease |
| 03/27/2008 | US20080076764 HPTPbeta as a target in treatment of angiogenesis mediated disorders |
| 03/27/2008 | US20080076763 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol for treating cancer and arthritis |
| 03/27/2008 | US20080076762 Novel 4-Aminopiperidine Derivatives |
| 03/27/2008 | US20080076761 Pharmaceutical compositions of clonazepam and method of use thereof |
| 03/27/2008 | US20080076760 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076757 Medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| 03/27/2008 | US20080076756 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076754 Substituted spiroheterocycles |
| 03/27/2008 | US20080076753 Substituted spiroheterocycles |
| 03/27/2008 | US20080076752 substituted structure of 3-amino-2-(2,5-difluorophenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one; 6-amino-7-phenyl-1,4-thiazepan-5-one; -amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one for treating neurological disorders such as Alzheimer's; inhibit the production of amyloid beta protein |
| 03/27/2008 | US20080076751 Azetidinone Derivatives and Methods of Use Thereof |
| 03/27/2008 | US20080076750 Azetidinone Derivatives and Methods of Use Thereof |
| 03/27/2008 | US20080076749 Stabilizing compositions for antibiotics and methods of use |
| 03/27/2008 | US20080076748 Palladium 31-oxo-15- methoxycarbonylmethyl- Rhodobacteriochlorin-131-(2-N3- trimethylammoniumethyl)amide acetate (salt); bacteriochlorophylls free of carbamate group; as photosensitizer for thermodynamic therapy and diagnosis; cancer, age related macular degeneration; killing viruses and bacteria |
| 03/27/2008 | US20080076746 Method of Treating Fish and Crustaceans With a Tellurium Based Immunomodulator |
| 03/27/2008 | US20080076745 Antibacterial amide macrocycles iv |
| 03/27/2008 | US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs |
| 03/27/2008 | US20080076743 osteoarthritis; administered once daily for at least about two weeks |
| 03/27/2008 | US20080076742 retinopathy of prematurity, diabetic retinopathy and macular degeneration; inhibiting retinal endothelial cell capillary morphogenesis, or inhibiting retinal angiogenesis; administering vitamin D; calcitriol; ergocalciferol; cholecalciferol |
| 03/27/2008 | US20080076741 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide |
| 03/27/2008 | US20080076740 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds; antiviral: improved pharmacokinetics; conjugate comprising a compound that inhibits HIV linked to one or more phosphonate groups |
| 03/27/2008 | US20080076739 anticancer, antitumor; Phosphoric acid mono-(2-(3-{2-[5-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-4-methoxy-5H-pyrrol-2-yl]-indol-1-yl]-1,1-dimethyl-3-oxo-propyl)-3-methylphenyl]ester |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | US20080076737 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
| 03/27/2008 | US20080076736 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
| 03/27/2008 | US20080076735 Cytoskeletal active compounds, composition and use |
| 03/27/2008 | US20080076734 Novel Agent for Suppressing Blood Pressure Elevation |
| 03/27/2008 | US20080076733 novel synthetic thiolatocobalamin; protects animal cells against oxidative stress damage; dietary supplement; also with vitamin B6 and a folate; cardiovascular disease, cerebrovascular disease, peripheral vascular disease, glaucoma, Alzheimer's disease, and dementia |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076730 Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy |
| 03/27/2008 | US20080076729 antiinflammatory; cystic fibrosis; |
| 03/27/2008 | US20080076728 Novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 03/27/2008 | US20080076727 antibody cocktails each recognizing a distinct epitope on the HMW-MAA protein; |
| 03/27/2008 | US20080076726 Methods and compositions for the treatment of asthma and related disorders |
| 03/27/2008 | US20080076725 less hygroscopic |
| 03/27/2008 | US20080076724 Novel polygalatenosides and use thereof as an antidepressant agent |
| 03/27/2008 | US20080076723 Inhibition of cathepsin K activity and the treatment and prevention of disease |
| 03/27/2008 | US20080076722 Hemostatic Agent and Method |
| 03/27/2008 | US20080076721 Use of branched chain fatty acid amino acid salts and compositions thereof |
| 03/27/2008 | US20080076720 a combinations of niacinamide for dry skin, improve skin aging, resist to wrinkle; treating skin disorders |
| 03/27/2008 | US20080076704 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 03/27/2008 | US20080076703 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080075798 Facial tissues |
| 03/27/2008 | US20080075797 Nutraceutical with Tart Cherries and Method of Treatment Therewith |
| 03/27/2008 | US20080075793 Antiviral compositions and methods of use |
| 03/27/2008 | US20080075789 Genes differentially expressed in bipolar disorder and/or schizophrenia |
| 03/27/2008 | US20080075788 Medical device that comprises a polymer and an ammonium sulfate salt as part of device, medical device that comprises powder component and a diammonium phosphate salt as part of device, and medical device that comprises an ammonium salt that is part of device; device may be bone cememt, suture, catheter |
| 03/27/2008 | US20080075786 Antimicrobial agents derived from cream |
| 03/27/2008 | US20080075785 Controlled release hydrogel formulation |
| 03/27/2008 | US20080075784 Mixture of drug such as cetirizine and cyclodextrin wherein the drug's dissolution rate has been retarded, or the the cyclodextrin's dissolution rate has been enhanced, or both; improved taste masking of pharmaceutical compositions of unpleasant-tasting drugs and cyclodextrin |
| 03/27/2008 | US20080075781 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules; improving efficiency and quality of pain management |
| 03/27/2008 | US20080075779 Additives And Methods For Enhancing Active Agent Elution Kinetics |